A study focused on immune regulatory molecules in peripheral blood mononuclear cells (PBMCs) examined PD-L1 mRNA expression in PBMCs with a significant fold change in metastatic breast cancer patients in contrast to healthy volunteers and primary breast cancer patients, indicating that PD-L1 was a specific gene related to disease progression [23]. The gene discussed is CD274; the disease is breast carcinoma.